Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Intravenous Nitroglycerin for Retained Placenta Extraction: a Multicenter Study
Brief Summary:
Primary objective The primary objective of this study is to see whether intravenous (IV) NTG 100-200 microgram can effectively help extract retained placenta as compared to placebo, in a randomized controlled multicenter study.
Secondary objective is to compare the hypotensive effects of NTG as compared to placebo, including others side effects such as headache, blood loss, or others.